Radiation therapy firm North American Scientific faces Nasdaq delisting
This article was originally published in Clinica
Executive Summary
North American Scientific (NAS) has been notified by Nasdaq that its failure to file a 10-Q report for the quarter ended January 31 means it could face delisting on April 1.